Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

被引：0

作者：

Panagiotis Alexopoulos

Lena-Sophie Gleixner

Lukas Werle

Felix Buhl

Nathalie Thierjung

Evangelia Giourou

Simone M. Kagerbauer

Philippos Gourzis

Hubert Kübler

Timo Grimmer

Igor Yakushev

Jan Martin

Alexander Kurz

Robert Perneczky

机构：

[1] Technical University of Munich,Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar

[2] University Hospital of Rion,Department of Psychiatry

[3] University of Patras,Department of Anaesthesiology, Klinikum Rechts der Isar

[4] Max Planck Institute of Psychiatry,Department of Urology, Klinikum Rechts der Isar

[5] Technical University of Munich,Department of Nuclear Medicine, Klinikum Rechts der Isar

[6] Technical University of Munich,Department of Psychiatry and Psychotherapy

[7] Technical University of Munich,Neuroepidemiology and Ageing Research Unit, Faculty of Medicine, School of Public Health

[8] Ludwig-Maximilians-Universität München,undefined

[9] The Imperial College of Science,undefined

[10] Technology and Medicine,undefined

[11] West London Mental Health NHS Trust,undefined

[12] German Center for Neurodegenerative Diseases (DZNE) Munich,undefined

来源：

European Archives of Psychiatry and Clinical Neuroscience | 2018年 / 268卷

关键词：

Soluble amyloid precursor protein β (sAPPβ); Biomarker-underpinned diagnoses; FDG-PET; Upstream biomarkers; Mild cognitive impairment; Dementia due to Alzheimer’s disease;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The established biomarkers of Alzheimer’s disease (AD) require invasive endeavours or presuppose sophisticated technical equipment. Consequently, new biomarkers are needed. Here, we report that plasma levels of soluble amyloid precursor protein β (sAPPβ), a protein of the initial phase of the amyloid cascade, were significantly lower in patients with symptomatic AD (21 with mild cognitive impairment due to AD and 44 with AD dementia) with AD-typical cerebral hypometabolic pattern compared with 27 cognitively healthy elderly individuals without preclinical AD. These findings yield further evidence for the potential of sAPPβ in plasma as an AD biomarker candidate.

引用

页码：519 / 524

页数：5

共 50 条

[21] Plasma Amyloid-β Forms in Alzheimer's Disease and Non-Alzheimer's Disease Patients
Le Bastard, Nathalie
Leurs, Judith
Blomme, Walter
De Deyn, Peter Paul
Engelborghs, Sebastiaan
JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (01) : 291 - 301
[22] Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
Coppus, Antonia M. W.
Schuur, Maaike
Vergeer, Jeanet
Janssens, A. Cecile J. W.
Oostra, Ben A.
Verbeek, Marcel M.
van Duijn, Cornelia M.
NEUROBIOLOGY OF AGING, 2012, 33 (09) : 1988 - 1994
[23] Platelet-Derived Secreted Amyloid-Precursor Protein-β as a Marker for Diagnosing Alzheimer's Disease
Marksteiner, Josef
Humpel, Christian
CURRENT NEUROVASCULAR RESEARCH, 2013, 10 (04) : 297 - 303
[24] Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease
Rissman, Robert A.
Trojanowski, John Q.
Shaw, Leslie M.
Aisen, Paul S.
JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (07) : 843 - 850
[25] Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice
Medina-Vera, Dina
Enache, Daniela
Tambaro, Simone
Abuhashish, Ethar
Rosell-Valle, Cristina
Winblad, Bengt
de Fonseca, Fernando Rodriguez
Bereczki, Erika
Nilsson, Per
BRAIN COMMUNICATIONS, 2022, 5 (01)
[26] Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets
Borroni, Barbara
Agosti, Chiara
Marcello, Elena
Di Luca, Monica
Padovani, Alessandro
EXPERIMENTAL GERONTOLOGY, 2010, 45 (01) : 53 - 56
[27] Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease
Yarchoan, Mark
Louneva, Natalia
Xie, Sharon X.
Swenson, Frank J.
Hu, William
Soares, Holly
Trojanowski, John Q.
Lee, Virginia M. -Y.
Kling, Mitchel A.
Shaw, Leslie M.
Chen-Plotkin, Alice
Wolk, David A.
Arnold, Steven E.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 333 (1-2) : 9 - 12
[28] Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease
Shi, Yachen
Gu, Lihua
Wang, Qing
Gao, Lijuan
Zhu, Jianli
Lu, Xiang
Zhou, Fangfang
Zhu, Dan
Zhang, Haisan
Xie, Chunming
Zhang, Zhijun
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2020, 75 (04): : 664 - 670
[29] Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease
Graff-Radford, Jonathan
Mielke, Michelle M.
Hofrenning, Ekaterina I.
Kouri, Naomi
Lesnick, Timothy G.
Moloney, Christina M.
Rabinstein, Alejandro
Cabrera-Rodriguez, Janisse N.
Othberg, Darren M. R.
Elski, Scott A. Przyb
Petersen, Ronald C.
Knopman, David S.
Dickson, Dennis W.
Jack, Clifford R.
Algeciras-Schimnich, Alicia
Nguyen, Aivi T.
Murray, Melissa E.
Vemuri, Prashanthi
NEUROBIOLOGY OF AGING, 2022, 119 : 1 - 7
[30] High performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, Akinori
Kaneko, Naoki
Villemagne, Victor L.
Kato, Takashi
Doecke, James
Dore, Vincent
Fowler, Chris
Li, Qiao-Xin
Martins, Ralph
Rowe, Christopher
Tomita, Taisuke
Matsuzaki, Katsumi
Ishii, Kenji
Ishii, Kazunari
Arahata, Yutaka
Iwamoto, Shinichi
Ito, Kengo
Tanaka, Koichi
Masters, Colin L.
Yanagisawa, Katsuhiko
NATURE, 2018, 554 (7691) : 249 - +

← 1 2 3 4 5 →